Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BR101801
i
Other names:
BR101801, BR 101801, BR2002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Boryung Group
Drug class:
PI3Kδ inhibitor, PI3Kγ inhibitor, DNA PK inhibitor
Related drugs:
‹
copanlisib (32)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
AZD8835 (1)
CB-006-3 (1)
linperlisib (1)
ACP-319 (0)
BGB-10188 (0)
CVL237 (0)
HSB-510 (0)
SL-901 (0)
TQ-B3525 (0)
ZX-101A (0)
GS-9820 (0)
HMPL-689 (0)
SHC014748M (0)
INCB040093 (0)
IOA-244 (0)
ME-401 (0)
IPI-549 (6)
CZC24832 (1)
AZD3458 (0)
ZX-4081 (0)
CC-115 (3)
M3814 (3)
AZD7648 (2)
NU7441 (1)
etidaligide (0)
M9831 (0)
XRD-0394 (0)
copanlisib (32)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
AZD8835 (1)
CB-006-3 (1)
linperlisib (1)
ACP-319 (0)
BGB-10188 (0)
CVL237 (0)
HSB-510 (0)
SL-901 (0)
TQ-B3525 (0)
ZX-101A (0)
GS-9820 (0)
HMPL-689 (0)
SHC014748M (0)
INCB040093 (0)
IOA-244 (0)
ME-401 (0)
IPI-549 (6)
CZC24832 (1)
AZD3458 (0)
ZX-4081 (0)
CC-115 (3)
M3814 (3)
AZD7648 (2)
NU7441 (1)
etidaligide (0)
M9831 (0)
XRD-0394 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MYC expression + MCL1 expression
Diffuse Large B Cell Lymphoma
MYC expression + MCL1 expression
Diffuse Large B Cell Lymphoma
venetoclax + BR101801
Sensitive: D – Preclinical
venetoclax + BR101801
Sensitive
:
D
venetoclax + BR101801
Sensitive: D – Preclinical
venetoclax + BR101801
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login